Review
Aug 2026
From Barrier Disruption and Immune Dysregulation to Targeted Therapies in Atopic Dermatitis
Current knowledge of barrier dysfunction, immune heterogeneity, molecular endotypes, molecular endotypes, microbiome imbalance, neuroimmune signaling, and mechanism-based therapies are synthesized.
Xin Luo, Yi-Chuan Li, Yinyi Feng et al.
· Clinical reviews in allergy... · 0 citations